chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: rapid intermittent resting heart beat (95 - 120 bpm); This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 18Mar2021 at 09:30 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma and penicillin allergy. Concomitant medications included loratadine (CLARITIN), triamcinolone acetonide (NASACORT), metformin (MANUFACTURER UNKNOWN), valaciclovir hydrochloride (VALACYCLOVIR) and fluticasone propionate, salmeterol xinafoate (ADVAIR); all for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 19:00, the patient experienced rapid intermittent resting heart beat (95 - 120 bpm). The patient underwent lab tests and procedures which included heart rate on18Mar2021 and the result was 95 - 120 beats per minute. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event heart beat increased was recovered on 23Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Swollen tongue, Tongue erythema
Clinical narrative: This was after only 1 shot of the Pfizer vaccine, was to concerned for my over all health to take the 2nd.  Face and Lip numbness for 6-10 days after shot.   Below symptoms continue till this day 7/28/2021. Tongue swollen, red like blisters, thin cuts on tongue, severe burning, painful gums, bumps on the walls of mouth and my teeth feel loose. My mouth feels inflamed and my tongue has inflammation continuously.  Off and on again burning swore throat, dry mouth continuously. My tongue feels like it's to big for my mouth, when eating it burns .Unable to eat at times my tongue is so swollen, irritated and burning.  Off and on loss of taste. Covid - Tongue  I'm going into the 5th month and I still have severe problems
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Blister, Circumoral swelling, Dry mouth, Feeding disorder
Clinical narrative: This was after only 1 shot of the Pfizer vaccine, was to concerned for my over all health to take the 2nd.  Face and Lip numbness for 6-10 days after shot.   Below symptoms continue till this day 7/28/2021. Tongue swollen, red like blisters, thin cuts on tongue, severe burning, painful gums, bumps on the walls of mouth and my teeth feel loose. My mouth feels inflamed and my tongue has inflammation continuously.  Off and on again burning swore throat, dry mouth continuously. My tongue feels like it's to big for my mouth, when eating it burns .Unable to eat at times my tongue is so swollen, irritated and burning.  Off and on loss of taste. Covid - Tongue  I'm going into the 5th month and I still have severe problems
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gingival discomfort, Glossitis, Hypoaesthesia, Hypoaesthesia oral, Loose tooth
Clinical narrative: This was after only 1 shot of the Pfizer vaccine, was to concerned for my over all health to take the 2nd.  Face and Lip numbness for 6-10 days after shot.   Below symptoms continue till this day 7/28/2021. Tongue swollen, red like blisters, thin cuts on tongue, severe burning, painful gums, bumps on the walls of mouth and my teeth feel loose. My mouth feels inflamed and my tongue has inflammation continuously.  Off and on again burning swore throat, dry mouth continuously. My tongue feels like it's to big for my mouth, when eating it burns .Unable to eat at times my tongue is so swollen, irritated and burning.  Off and on loss of taste. Covid - Tongue  I'm going into the 5th month and I still have severe problems
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Rash erythematous, Stomatitis, Swollen tongue, Throat irritation
Clinical narrative: This was after only 1 shot of the Pfizer vaccine, was to concerned for my over all health to take the 2nd.  Face and Lip numbness for 6-10 days after shot.   Below symptoms continue till this day 7/28/2021. Tongue swollen, red like blisters, thin cuts on tongue, severe burning, painful gums, bumps on the walls of mouth and my teeth feel loose. My mouth feels inflamed and my tongue has inflammation continuously.  Off and on again burning swore throat, dry mouth continuously. My tongue feels like it's to big for my mouth, when eating it burns .Unable to eat at times my tongue is so swollen, irritated and burning.  Off and on loss of taste. Covid - Tongue  I'm going into the 5th month and I still have severe problems
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tongue discomfort, Tongue injury
Clinical narrative: This was after only 1 shot of the Pfizer vaccine, was to concerned for my over all health to take the 2nd.  Face and Lip numbness for 6-10 days after shot.   Below symptoms continue till this day 7/28/2021. Tongue swollen, red like blisters, thin cuts on tongue, severe burning, painful gums, bumps on the walls of mouth and my teeth feel loose. My mouth feels inflamed and my tongue has inflammation continuously.  Off and on again burning swore throat, dry mouth continuously. My tongue feels like it's to big for my mouth, when eating it burns .Unable to eat at times my tongue is so swollen, irritated and burning.  Off and on loss of taste. Covid - Tongue  I'm going into the 5th month and I still have severe problems
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Tender lymph node under left arm; Swollen lymph node under left arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7533) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included birth control pills (unspecified), ademetionine (SAM-E),LUTEIN (unspecified), magnesium (MANUFACTURER UNKNOWN) and Bu (unspecified); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received minocycline (MANUFACTURER UNKNOWN), amoxicillin (MANUFACTURER UNKNOWN), ciprofloxacin (CIPRO); all started on an unknown date for an unknown indication and experienced allergy with all. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 19:00, the patient experienced swollen and tender lymph node under left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events swollen lymph node under left arm and tender lymph node under left arm were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Tender lymph node under left arm; Swollen lymph node under left arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7533) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included birth control pills (unspecified), ademetionine (SAM-E),LUTEIN (unspecified), magnesium (MANUFACTURER UNKNOWN) and Bu (unspecified); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received minocycline (MANUFACTURER UNKNOWN), amoxicillin (MANUFACTURER UNKNOWN), ciprofloxacin (CIPRO); all started on an unknown date for an unknown indication and experienced allergy with all. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 19:00, the patient experienced swollen and tender lymph node under left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events swollen lymph node under left arm and tender lymph node under left arm were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Chills, Fatigue, Nausea, Peripheral swelling
Clinical narrative: Chills; Fever; Extreme tiredness; Nausea; Swelling; Extreme tenderness; Slight pain under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to aluminium when used as a preservative for an injection. Concomitant medications included vit B12 (MANUFACTURER UKNOWN), vit D (MANUFACTURER UKNOWN) and fiber. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, approximately 18 hours after second vaccine the patient experienced chills, fever, extreme tiredness and nausea. On 31Mar2021, approximately 24 hours after second vaccine the patient experienced swelling, extreme tenderness and slight pain under left armpit. After about two days, the patient did not experience symptoms any longer. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills, fever, extreme tiredness, nausea, swelling, extreme tenderness and slight pain under left armpit was resolved on 02Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; Fever; Extreme tiredness; Nausea; Swelling; Extreme tenderness; Slight pain under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to aluminium when used as a preservative for an injection. Concomitant medications included vit B12 (MANUFACTURER UKNOWN), vit D (MANUFACTURER UKNOWN) and fiber. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, approximately 18 hours after second vaccine the patient experienced chills, fever, extreme tiredness and nausea. On 31Mar2021, approximately 24 hours after second vaccine the patient experienced swelling, extreme tenderness and slight pain under left armpit. After about two days, the patient did not experience symptoms any longer. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills, fever, extreme tiredness, nausea, swelling, extreme tenderness and slight pain under left armpit was resolved on 02Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: Chills; Fever; Extreme tiredness; Nausea; Swelling; Extreme tenderness; Slight pain under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to aluminium when used as a preservative for an injection. Concomitant medications included vit B12 (MANUFACTURER UKNOWN), vit D (MANUFACTURER UKNOWN) and fiber. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, approximately 18 hours after second vaccine the patient experienced chills, fever, extreme tiredness and nausea. On 31Mar2021, approximately 24 hours after second vaccine the patient experienced swelling, extreme tenderness and slight pain under left armpit. After about two days, the patient did not experience symptoms any longer. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills, fever, extreme tiredness, nausea, swelling, extreme tenderness and slight pain under left armpit was resolved on 02Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling, Tenderness
Clinical narrative: Chills; Fever; Extreme tiredness; Nausea; Swelling; Extreme tenderness; Slight pain under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to aluminium when used as a preservative for an injection. Concomitant medications included vit B12 (MANUFACTURER UKNOWN), vit D (MANUFACTURER UKNOWN) and fiber. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, approximately 18 hours after second vaccine the patient experienced chills, fever, extreme tiredness and nausea. On 31Mar2021, approximately 24 hours after second vaccine the patient experienced swelling, extreme tenderness and slight pain under left armpit. After about two days, the patient did not experience symptoms any longer. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills, fever, extreme tiredness, nausea, swelling, extreme tenderness and slight pain under left armpit was resolved on 02Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Administration site discharge, Ocular hyperaemia, Pruritus
Clinical narrative: Pink eye; Pink eye, weeping and crusting,swelling, grittiness; crusting; Pink eye, weeping and crusting,swelling, grittiness; grittiness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old-non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via unspecified route of administration in the left arm on 05Apr2021 at 09:00 (at the age of 63-years-old) as a single dose for Covid-19 immunisation. The patient's medical history included shell fish allergy. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 21:30, the patient experienced pink eye, weeping and crusting, swelling and grittiness. The patient did not receive treatment for the reported event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of pink eye, weeping and crusting, swelling and grittiness was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Conjunctivitis, Eye swelling, Eyelid margin crusting, Foreign body sensation in eyes, Lacrimation increased
Clinical narrative: Pink eye; Pink eye, weeping and crusting,swelling, grittiness; crusting; Pink eye, weeping and crusting,swelling, grittiness; grittiness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old-non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via unspecified route of administration in the left arm on 05Apr2021 at 09:00 (at the age of 63-years-old) as a single dose for Covid-19 immunisation. The patient's medical history included shell fish allergy. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 21:30, the patient experienced pink eye, weeping and crusting, swelling and grittiness. The patient did not receive treatment for the reported event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of pink eye, weeping and crusting, swelling and grittiness was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 23Feb2021 at 16:00 (at the age of 78-year-old) as a single dose for COVID-19 immunisation. Medical history included glaucoma. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route in left arm on 02Feb2021 at 16:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Feb2021 at 16:00, post second vaccination, the patient experienced tinnitus which persisted since then. The patient did not receive any treatment for the event. The clinical outcome of the event tinnitus was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Headache, Hyperhidrosis, Restlessness
Clinical narrative: Congestion; Body Aches; Cough; Severe sweats; Severe headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left leg on 31Mar2021 at 15:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 18:00, the patient experienced severe sweats, chills, severe headache, body aches, congestion and cough. It was reported that the events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events severe sweats, chills, severe headache, body aches, congestion and cough was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sinusitis
Clinical narrative: Congestion; Body Aches; Cough; Severe sweats; Severe headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left leg on 31Mar2021 at 15:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 18:00, the patient experienced severe sweats, chills, severe headache, body aches, congestion and cough. It was reported that the events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events severe sweats, chills, severe headache, body aches, congestion and cough was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Headache, Hyperhidrosis, Nasal congestion
Clinical narrative: Congestion; Body Aches; Cough; Severe sweats; Severe headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left leg on 31Mar2021 at 15:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 18:00, the patient experienced severe sweats, chills, severe headache, body aches, congestion and cough. It was reported that the events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events severe sweats, chills, severe headache, body aches, congestion and cough was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: Congestion; Body Aches; Cough; Severe sweats; Severe headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left leg on 31Mar2021 at 15:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 18:00, the patient experienced severe sweats, chills, severe headache, body aches, congestion and cough. It was reported that the events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events severe sweats, chills, severe headache, body aches, congestion and cough was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Dizziness, Tinnitus
Clinical narrative: Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 27Mar2021 at 09:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included Meniere's disease. The patient had no known allergies to medications, food, or other products. Concomitant medications included hydrochlorothiazide 25 mg (MANUFACTURER UNKNOWN) and levothyroxine 75 mcg (MANUFACTURER UNKNOWN); both taken for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 05Mar2021 at 14:45 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 14:00, the patient experienced dizziness. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event dizziness was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 27Mar2021 at 09:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included Meniere's disease. The patient had no known allergies to medications, food, or other products. Concomitant medications included hydrochlorothiazide 25 mg (MANUFACTURER UNKNOWN) and levothyroxine 75 mcg (MANUFACTURER UNKNOWN); both taken for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 05Mar2021 at 14:45 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 14:00, the patient experienced dizziness. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event dizziness was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Immediate post-injection reaction, Rash, Skin burning sensation, Skin discolouration
Clinical narrative: Bruised area just above wrist of vaccination arm; Felt slight burning in right hand; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 3782) via an unspecified route of administration in the right arm on 04Apr2021 at 14:45 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included Gastroesophageal Reflux Disease (GERD). Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) 40 mg, taken from an unknown date for an unspecified indication. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient underwent COVID test (nasal swab) and the result was negative. On 04Apr2021, immediately after the injection, the patient felt slight burning in right hand. On 05Apr2021 at 08:00, the next morning, the patient noticed a bruised area just above wrist of vaccination arm. The patient reported no contact in that area the previous day. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events felt slight burning in right hand and bruised area just above wrist of vaccination arm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Contusion, SARS-CoV-2 test
Clinical narrative: Bruised area just above wrist of vaccination arm; Felt slight burning in right hand; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 3782) via an unspecified route of administration in the right arm on 04Apr2021 at 14:45 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included Gastroesophageal Reflux Disease (GERD). Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) 40 mg, taken from an unknown date for an unspecified indication. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient underwent COVID test (nasal swab) and the result was negative. On 04Apr2021, immediately after the injection, the patient felt slight burning in right hand. On 05Apr2021 at 08:00, the next morning, the patient noticed a bruised area just above wrist of vaccination arm. The patient reported no contact in that area the previous day. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events felt slight burning in right hand and bruised area just above wrist of vaccination arm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Dizziness, Dyspnoea, Palpitations
Clinical narrative: fast heart beat; difficulty in breathing; dizziness; confusion; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:00 the patient had experienced fast heartbeat, difficulty in breathing, dizziness and confusion after one hour of vaccine administration which was lasted for about 3 minutes or less. The reaction repeated again after 30 hours and lasted for about 2 minutes. But he reported only the effect that happened after 30 hours and not the initial experience. The clinical outcome of the events fast heartbeat, difficulty in breathing, dizziness and confusion was resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dizziness, Dyspnoea, Palpitations
Clinical narrative: fast heart beat; difficulty in breathing; dizziness; confusion; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:00 the patient had experienced fast heartbeat, difficulty in breathing, dizziness and confusion after one hour of vaccine administration which was lasted for about 3 minutes or less. The reaction repeated again after 30 hours and lasted for about 2 minutes. But he reported only the effect that happened after 30 hours and not the initial experience. The clinical outcome of the events fast heartbeat, difficulty in breathing, dizziness and confusion was resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: Within two hours of the vaccine, I started to have itching all over my body under my skin. There was no rash that was visible. I took some Zyrtec for one month and the itch was present the whole time for four weeks. It seemed to be worse some days than others. I got sores in my mouth on the same day. Over time these became rough areas on the top of my mouth and all around my mouth. They were painful and certain foods irritate the sores. I still have the rough patches in my mouth after 12 weeks. My doctor prescribed Clotrimazole Lozenges which I take 4 times daily and it seems to help.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Food interaction, Pain, Pruritus, Stomatitis
Clinical narrative: Within two hours of the vaccine, I started to have itching all over my body under my skin. There was no rash that was visible. I took some Zyrtec for one month and the itch was present the whole time for four weeks. It seemed to be worse some days than others. I got sores in my mouth on the same day. Over time these became rough areas on the top of my mouth and all around my mouth. They were painful and certain foods irritate the sores. I still have the rough patches in my mouth after 12 weeks. My doctor prescribed Clotrimazole Lozenges which I take 4 times daily and it seems to help.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Joint range of motion decreased, Mobility decreased
Clinical narrative: about 3 days after shot, except sore arm. Then pain started in shoulder joint down through the muscle and side of the bone to the wrist. Both sides of my wrist hurt. The pain was constant and moving was unbearable. Tried to use heat, cold, and vibrator to relieve the pain. Pain in the morning started as bearable but it would get worse as the day went on.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Bone pain, Myalgia, Pain, Pain in extremity
Clinical narrative: about 3 days after shot, except sore arm. Then pain started in shoulder joint down through the muscle and side of the bone to the wrist. Both sides of my wrist hurt. The pain was constant and moving was unbearable. Tried to use heat, cold, and vibrator to relieve the pain. Pain in the morning started as bearable but it would get worse as the day went on.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster, Hypoaesthesia, Magnetic resonance imaging spinal abnormal, Sensory loss, Spinal cord disorder
Clinical narrative: 3/1 and 3/25/21 patient received COVID19 vaccines (Pfizer)  3/8/21 developed a shingles rash over the lower part of the LEFT breast, wrapping around the back Prior hx chicken pox, first time episode of shingles -- > 7  Days of oral valacyclovir. States her vesicular rashes were all scabbed over within 2 weeks of treatment.  3/28 Left finger, toe, and lower breast tingling that progressed over time to impact her entire left arm, leg, and trunk from breast level down; torso tightness in the same distribution of her shingles rash By 4/9, tingling had risen up the left leg to the groin -- > MRI cervical spine on 4/9 noncontrast showed C3 and C7-T1 lesions -- > MRI C/T/L spine on 4/14 with enhancing lesions at multiple cervical and thoracic levels -- > LP on 4/14 with borderline OCB; HSV and VZV negative. (Cells/glucose/protein: 3/77/29) -- > MRI brain 4/15 with 'nonspecific' T2/FLAIR hyperintense lesions. Received IV acyclovir for 6 days 4/14-4/20 -- > Received IV acyclovir for 6 days 4/14-4/20, then 4/20-4/22/21 IV solumedrol X 3 days without noticeable improvement  MRI brain and cervical spine with and without contrast done July 16, 2021 showed no new lesions and resolution of enhancement.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster, SARS-CoV-2 test
Clinical narrative: 3/1 and 3/25/21 patient received COVID19 vaccines (Pfizer)  3/8/21 developed a shingles rash over the lower part of the LEFT breast, wrapping around the back Prior hx chicken pox, first time episode of shingles -- > 7  Days of oral valacyclovir. States her vesicular rashes were all scabbed over within 2 weeks of treatment.  3/28 Left finger, toe, and lower breast tingling that progressed over time to impact her entire left arm, leg, and trunk from breast level down; torso tightness in the same distribution of her shingles rash By 4/9, tingling had risen up the left leg to the groin -- > MRI cervical spine on 4/9 noncontrast showed C3 and C7-T1 lesions -- > MRI C/T/L spine on 4/14 with enhancing lesions at multiple cervical and thoracic levels -- > LP on 4/14 with borderline OCB; HSV and VZV negative. (Cells/glucose/protein: 3/77/29) -- > MRI brain 4/15 with 'nonspecific' T2/FLAIR hyperintense lesions. Received IV acyclovir for 6 days 4/14-4/20 -- > Received IV acyclovir for 6 days 4/14-4/20, then 4/20-4/22/21 IV solumedrol X 3 days without noticeable improvement  MRI brain and cervical spine with and without contrast done July 16, 2021 showed no new lesions and resolution of enhancement.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Demyelination, Herpes zoster, Hypoaesthesia, Magnetic resonance imaging spinal abnormal, Myelitis transverse
Clinical narrative: 3/1 and 3/25/21 patient received COVID19 vaccines (Pfizer)  3/8/21 developed a shingles rash over the lower part of the LEFT breast, wrapping around the back Prior hx chicken pox, first time episode of shingles -- > 7  Days of oral valacyclovir. States her vesicular rashes were all scabbed over within 2 weeks of treatment.  3/28 Left finger, toe, and lower breast tingling that progressed over time to impact her entire left arm, leg, and trunk from breast level down; torso tightness in the same distribution of her shingles rash By 4/9, tingling had risen up the left leg to the groin -- > MRI cervical spine on 4/9 noncontrast showed C3 and C7-T1 lesions -- > MRI C/T/L spine on 4/14 with enhancing lesions at multiple cervical and thoracic levels -- > LP on 4/14 with borderline OCB; HSV and VZV negative. (Cells/glucose/protein: 3/77/29) -- > MRI brain 4/15 with 'nonspecific' T2/FLAIR hyperintense lesions. Received IV acyclovir for 6 days 4/14-4/20 -- > Received IV acyclovir for 6 days 4/14-4/20, then 4/20-4/22/21 IV solumedrol X 3 days without noticeable improvement  MRI brain and cervical spine with and without contrast done July 16, 2021 showed no new lesions and resolution of enhancement.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: 3/1 and 3/25/21 patient received COVID19 vaccines (Pfizer)  3/8/21 developed a shingles rash over the lower part of the LEFT breast, wrapping around the back Prior hx chicken pox, first time episode of shingles -- > 7  Days of oral valacyclovir. States her vesicular rashes were all scabbed over within 2 weeks of treatment.  3/28 Left finger, toe, and lower breast tingling that progressed over time to impact her entire left arm, leg, and trunk from breast level down; torso tightness in the same distribution of her shingles rash By 4/9, tingling had risen up the left leg to the groin -- > MRI cervical spine on 4/9 noncontrast showed C3 and C7-T1 lesions -- > MRI C/T/L spine on 4/14 with enhancing lesions at multiple cervical and thoracic levels -- > LP on 4/14 with borderline OCB; HSV and VZV negative. (Cells/glucose/protein: 3/77/29) -- > MRI brain 4/15 with 'nonspecific' T2/FLAIR hyperintense lesions. Received IV acyclovir for 6 days 4/14-4/20 -- > Received IV acyclovir for 6 days 4/14-4/20, then 4/20-4/22/21 IV solumedrol X 3 days without noticeable improvement  MRI brain and cervical spine with and without contrast done July 16, 2021 showed no new lesions and resolution of enhancement.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood glucose, Herpes simplex test negative, Herpes zoster, Lumbar puncture, Magnetic resonance imaging head abnormal
Clinical narrative: 3/1 and 3/25/21 patient received COVID19 vaccines (Pfizer)  3/8/21 developed a shingles rash over the lower part of the LEFT breast, wrapping around the back Prior hx chicken pox, first time episode of shingles -- > 7  Days of oral valacyclovir. States her vesicular rashes were all scabbed over within 2 weeks of treatment.  3/28 Left finger, toe, and lower breast tingling that progressed over time to impact her entire left arm, leg, and trunk from breast level down; torso tightness in the same distribution of her shingles rash By 4/9, tingling had risen up the left leg to the groin -- > MRI cervical spine on 4/9 noncontrast showed C3 and C7-T1 lesions -- > MRI C/T/L spine on 4/14 with enhancing lesions at multiple cervical and thoracic levels -- > LP on 4/14 with borderline OCB; HSV and VZV negative. (Cells/glucose/protein: 3/77/29) -- > MRI brain 4/15 with 'nonspecific' T2/FLAIR hyperintense lesions. Received IV acyclovir for 6 days 4/14-4/20 -- > Received IV acyclovir for 6 days 4/14-4/20, then 4/20-4/22/21 IV solumedrol X 3 days without noticeable improvement  MRI brain and cervical spine with and without contrast done July 16, 2021 showed no new lesions and resolution of enhancement.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging spinal abnormal, Paraesthesia, Protein total, Rash vesicular, Scab
Clinical narrative: 3/1 and 3/25/21 patient received COVID19 vaccines (Pfizer)  3/8/21 developed a shingles rash over the lower part of the LEFT breast, wrapping around the back Prior hx chicken pox, first time episode of shingles -- > 7  Days of oral valacyclovir. States her vesicular rashes were all scabbed over within 2 weeks of treatment.  3/28 Left finger, toe, and lower breast tingling that progressed over time to impact her entire left arm, leg, and trunk from breast level down; torso tightness in the same distribution of her shingles rash By 4/9, tingling had risen up the left leg to the groin -- > MRI cervical spine on 4/9 noncontrast showed C3 and C7-T1 lesions -- > MRI C/T/L spine on 4/14 with enhancing lesions at multiple cervical and thoracic levels -- > LP on 4/14 with borderline OCB; HSV and VZV negative. (Cells/glucose/protein: 3/77/29) -- > MRI brain 4/15 with 'nonspecific' T2/FLAIR hyperintense lesions. Received IV acyclovir for 6 days 4/14-4/20 -- > Received IV acyclovir for 6 days 4/14-4/20, then 4/20-4/22/21 IV solumedrol X 3 days without noticeable improvement  MRI brain and cervical spine with and without contrast done July 16, 2021 showed no new lesions and resolution of enhancement.